Abstract
Rheumatic diseases are complex diseases involving systemic connective tissues. Although the manifestations of rheumatic diseases in joints, muscles, and other motor system have been well known, the ophthalmologists’ awareness of rheumatic ocular disease is still inadequate. Rheumatic ophthalmopathy often becomes a disease difficult to diagnose that confuses clinicians, those who might neglect the screen of systemic diseases, thus leading to misdiagnosis and missed diagnosis. Therefore, the diagnosis and treatment of rheumatic ocular disease need to be combined with the concept of integrative medicine starting from the understanding of systemic diseases. The section introduces the relationship between rheumatism-caused systemic disease and ocular diseases; classification, clinical manifestations, and differential diagnosis of rheumatic ocular diseases; and treatment of systemic diseases. Thus ophthalmologists can understand and attach importance to ocular damage resulting from rheumatism, clear about the clinical manifestations of rheumatic diseases and rheumatic ocular diseases, clarify the etiology timely, and cooperate with rheumatologists, and thus then it would lead to treatment for the “disease,” rather than “symptoms.” At the same time, the section indicates the establishment of the concept for the interdisciplinary cooperative treatment of ophthalmology and rheumatic department for rheumatic ocular diseases, and discusses the possibility of developing specialized clinic for rheumatic ocular diseases, and standardized system for the diagnosis and treatment of rheumatic ocular diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Peizeng Y. Classifications of uveitis. Beijing: People’s Medical Publishing House; 2004.
Gabriel SE. KELLEY’S textbook of rheumatology (Chinese version). Translated by Li Zhanguo, Tang Fulin. Beijing: Peking University Medical Press; 2011.
Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777–83.
Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet. 1990;335:1078–980.
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
Michet CJ Jr, McKenna CH, Luthra HS, et al. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104:74–8.
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.
Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J Am Acad Dermatol. 2008;59:113–21.
Mohsenin A, Huang JJ. Ocular manifestations of systemic inflammatory diseases. Conn Med. 2012;76:533–44.
Rothschild PR, Pagnoux C, Seror R, et al. Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Semin Arthritis Rheum. 2013;42:507–14.
Edelsten C, Lee V, Bentley CR, et al. evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51–6.
Jasse L, Vukusic S, Durand-Dubief F, et al. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability. Mult Scler. 2013;19:1618–26.
Liozon E, Ly KH, Robert PY. Ocular complications of giant cell arteritis. Rev Med Interne. 2013;34:421–30.
Zhengang W. Selected cases of eye & ENT involved in rheumatic diseases. Beijing: People’s Medical Publishing House Co., Ltd.; 2012.
Horai R, Caspi RR. Cytokines in autoimmune uveitis. J Interf Cytokine Res. 2011;31:733–44.
McCluskey P, Powell RJ. The eye in systemic inflammatory diseases. Lancet. 2004;364:2125–33.
Menezo V, Lightman S. The eye in systemic vasculitis. Clin Med. 2004;4:250–4.
Shepherd JB 3rd. Ocular vasculitis. Curr Rheumatol Rep. 2003;5:100–6.
Herbort CP, Cimino L, Abu El Asrar AM, et al. Ocular vasculitis: a multidisciplinary approach. Curr Opin Rheumatol. 2005;17:25–33.
Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.
Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus. Clin Exp Nephrol. 2013;17:603–6.
Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis a rare disease often associated with systemic diseases and infections—a systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57–64.
Bao T, Yang Z, Zhouying Q. Comparison and analysis of data obtained in two national sampling surveys of disability. Chin J Spec Educ. 2007;8:54–6.
Saeki Y, Matsui T, Saisho K, et al. Current treatments of rheumatoid arthritis: from the ‘NinJa’ registry. Expert Rev Clin Immunol. 2012;8:455–65.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Wang, Z., Hong, Y. (2020). Rheumatism and Rheumatic Ophthalmology from the Prospective of Integrative Medicine. In: Wang, N. (eds) Integrative Ophthalmology. Advances in Visual Science and Eye Diseases, vol 3. Springer, Singapore. https://doi.org/10.1007/978-981-13-7896-6_32
Download citation
DOI: https://doi.org/10.1007/978-981-13-7896-6_32
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7895-9
Online ISBN: 978-981-13-7896-6
eBook Packages: MedicineMedicine (R0)